| |
Company
Roster
|
|
Total
Insiders : |
29 |
|
|
|
Total
Direct Shares :
|
17,633,250 |
|
|
Total
Indirect Shares :
|
17,312,353 |
| |
%
Held by Insiders:
|
24.96% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Kulkarni Samarth |
|
2024-04-15 |
208,122 |
2024-04-15 |
200,000 |
| Prasad Raju |
|
2024-03-15 |
6,476 |
2024-03-14 |
0 |
| Kasinger James R. |
|
2024-03-12 |
61,174 |
|
0 |
| Morrow Phuong Khanh |
Chief Medical Officer |
2023-05-24 |
4,411 |
2023-05-23 |
0 |
| Smith Brendan |
Chief Financial Officer |
2023-02-21 |
5,072 |
2022-10-14 |
0 |
| Klein Lawrence Otto |
CBO & COO |
2022-03-14 |
26,797 |
2019-01-02 |
0 |
| Ho Tony W |
Executive VP, Head of R&D |
2021-12-06 |
52,364 |
2018-08-01 |
0 |
| Tomsicek Michael John |
Chief Financial Officer |
2021-08-06 |
1,891 |
2020-08-03 |
0 |
| Novak Rodger |
President, Director |
2021-06-30 |
573,007 |
|
0 |
| Bolzon Bradley J Phd |
Director |
2021-06-29 |
0 |
2021-07-19 |
498,558 |
| Behbahani Ali |
Director |
2020-08-13 |
256 |
2020-08-13 |
14 |
| Treco Douglas A |
Director |
2020-06-11 |
2,000 |
|
0 |
| Cagnoni Pablo J |
Director |
2019-11-12 |
0 |
2018-07-03 |
0 |
| Vertex Pharmaceuticals Inc / Ma |
10% Owner |
2018-12-27 |
5,380,940 |
2018-12-21 |
0 |
| Emster Kurt Von |
Director |
2018-06-05 |
90,000 |
2018-12-18 |
1,171,268 |
| Woiwode Thomas |
Director |
2018-05-15 |
5,629 |
2018-05-15 |
640,014 |
| Dylan-Hyde Tyler |
Chief Legal Officer |
2018-01-16 |
25,204 |
|
0 |
| Bayer Global Investments B.v. |
10% Owner |
2018-01-05 |
0 |
2018-01-05 |
5,708,747 |
| Versant Ventures V (canada), L.p. |
10% Owner |
2017-09-05 |
0 |
2017-09-05 |
0 |
| Coles N Anthony |
Director |
2016-10-24 |
0 |
2016-10-24 |
70,000 |
| Hadley Harbor Master Investors (cayman) L.p. |
10% Owner |
2016-10-24 |
744,380 |
2016-10-24 |
0 |
| Lundberg Sven Ante |
Chief Scientific Officer |
2016-10-24 |
505,217 |
2016-10-24 |
505,617 |
| Glaxosmithkline Plc |
10% Owner |
2016-10-24 |
0 |
2016-10-24 |
3,220,627 |
| George Simeon |
|
2016-10-24 |
0 |
2024-02-27 |
769,196 |
| Versant Venture Capital V (canada), Lp |
10% Owner |
2016-10-24 |
0 |
2018-04-24 |
115,645 |
| Celgene Corp /de/ |
10% Owner |
2016-10-24 |
4,834,980 |
2018-11-21 |
4,173,019 |
| Bayer Aktiengesellschaft |
10% Owner |
2016-10-18 |
5,105,330 |
|
0 |
| Subramanian Kala |
|
|
0 |
|
0 |
| Versant Ophthalmic Affiliates I, L.p. |
10% Owner |
|
0 |
2016-10-18 |
239,648 |
|
0.18 (0.34%) 
